Arkolith/Insider Trading/NXL/Form 4

Owens David

Chief Medical Officer, DirectorNexalin Technology, Inc. (NXL) · full profile →Form 4 · filed Jan 24, 2025
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 23, 2025Buy(P)1K$2.70$3K152K
Jan 13, 2025Buy(P)2K$2.50$5K151K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001829126-25-000368) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML